A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program)
NCT ID: NCT03333252
Last Updated: 2024-04-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
352 participants
INTERVENTIONAL
2018-01-29
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Caring for the Caregiver Network
NCT03049501
Developing a Communication Intervention for People With Memory Challenges and Their Care Partners
NCT05143255
Coordinating Center for Caregiver Intervention Trial
NCT00177489
Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care
NCT04571502
Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia
NCT06264362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Interested participants (caregivers) can contact us via telephone or email after seeing a flyer posted in various WCM/NYP locations including the Irving Sherwood Wright Center on Aging. One of our research associates (RA) will provide more information about the study to potential participants. The trained RA will use a telephone script with consent language to obtain permission to ask them questions to determine their eligibility through a phone screen script. If the participant is ineligible for the study, all screening data will be deleted. If the caregiver participant is eligible for the study, an appointment will be provided, and one of our RAs will visit the participants (caregiver and care recipient) and conduct the baseline assessment at the participants' home in their preferred language (Spanish or English). This assessment with the caregiver will last between 2 and 3 hours, additionally the assessment with the care recipient will last approximately 1.5 hours. We will use Qualtrics (online survey/data collection service) to administer the assessments.
The baseline assessment with the caregiver (CG) consists of a series of questionnaires assessing the level of burden, and depression perceived by the CG while providing the care, the amount of social support available to the CG, and the self-care activities of the CG to provide continuing care to their loved ones. The assessment with the care recipient consists of measures of processing speed (digit symbol). In addition, the care recipient will complete a computer-based questionnaire assessing their quality of life. The assessment with the caregiver and care recipient might not be completed in the same home visit. The study protocol allows multiple visits to complete the assessments.
During the baseline home visit, the RA will go over the written informed consent and HIPAA authorization with the participants (caregiver and care recipient). The assessment will not begin unless the participant has a full understanding of the informed consent form and has signed the form. The care recipient will additionally be given a Consent Feedback Tool, as an added step to make sure they understand the consent form since they have mild cognitive impairment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Condition
Exposing caregivers to caregiving-related information and care recipients to cognitive training tasks
Intervention Condition
Caregivers will access caregiving related information. Care Recipients will access cognitive training program
Control Condition
Exposing caregivers to Nutrition and Health promotional material. The care recipients are exposed to plain words games from computer.
Control Condition
Caregivers will access Nutrition and Health Promotion material. Care Recipients will access words and card games
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention Condition
Caregivers will access caregiving related information. Care Recipients will access cognitive training program
Control Condition
Caregivers will access Nutrition and Health Promotion material. Care Recipients will access words and card games
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Providing care for a friend or relative with AD for a minimum of eight hours per week for at least the past six months
* Being over the age of 21 years
* Living with or nearby the patient
* Having a telephone
* Planning to stay in the study geographic area for the duration of the study
* MMSE 18 - 25 (with Mungus age and education correction) (if scores high on MMSE, the care recipient has to score 1.0 in the Clinical Dementia Rating Scale (CDR))
* Needs help with higher level of IADL (e.g., managing finances, helping remember appointments, handling medications)
* Show memory problems
Exclusion Criteria
* Paid caregivers
* Has terminal illness with life expectancy of 6 months or less
CARE RECIPIENT (CR)
* Lives in nursing home or facility
* Going to be placed in a facility in the next 6 months
* Has terminal illness with life expectancy of 6 months or less
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sara J. Czaja, PhD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami Miller School of Medicine
Miami, Florida, United States
Weill Cornell Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1803019068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.